Avicanna: A Leader in Biopharmaceutical Advancements Using Cannabinoids

On Oct 15, 2020

Aras Azadian, CEO of Avicanna Inc. discusses why their are positioned to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, Latin America, Europe and Asia.

Join us at an upcoming event! http://www.cambridgehouse.com

Be part of our investment community:
http://www.cambridgehouse.com/
https://twitter.com/cambridge
https://www.facebook.com/cambridgehouseconferences
https://www.linkedin.com/company/cambridge-house-international/